Panbela Therapeutics Inc (PBLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,578 | 1,285 | 11,867 | 9,022 | 2,449 |
| Receivables | 183 | 49 | 321 | 323 | 361 |
| TOTAL | $3,060 | $1,777 | $12,279 | $9,757 | $3,093 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 8,742 | 3,201 | 593 | 56 | 51 |
| TOTAL | $8,742 | $3,201 | $593 | $56 | $51 |
| Total Assets | $11,802 | $4,978 | $12,872 | $9,813 | $3,144 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,000 | 1,000 | N/A | N/A | 116 |
| Accounts payable and accrued liabilities | 9,939 | 2,865 | 640 | 554 | 597 |
| Accrued Expenses | 1,379 | 3,318 | 2,020 | 811 | 304 |
| TOTAL | $12,318 | $7,833 | $2,660 | $1,365 | $1,759 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,194 | 5,194 | N/A | N/A | N/A |
| TOTAL | $4,194 | $5,194 | $N/A | $N/A | $N/A |
| Total Liabilities | $16,512 | $13,027 | $2,660 | $1,365 | $1,759 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,855 | 24 | 1 | N/A | N/A |
| Common Shares | N/A | N/A | N/A | 10 | 7 |
| Retained earnings | -125,497 | -91,094 | -56,161 | -46,026 | -41,258 |
| Other shareholders' equity | 744 | 759 | 133 | -384 | 305 |
| TOTAL | $-4,710 | $-8,049 | $10,212 | $8,448 | $1,385 |
| Total Liabilities And Equity | $11,802 | $4,978 | $12,872 | $9,813 | $3,144 |